Addressing conflicts of interest in nanotechnology oversight

&
Journal of Nanoparticle Research 14:664-8 (2012)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,590

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Kevin C. Elliott. Is a Little Pollution Good for You? Incorporating Societal Values in Environmental Research. [REVIEW]Linda S. Jones - 2012 - Environmental Ethics 34 (3):335-336.
Researcher Views About Funding Sources and Conflicts of Interest in Nanotechnology.Katherine A. McComas - 2012 - Science and Engineering Ethics 18 (4):699-717.
Scientific Research on Nanotechnology in Latin American Journals Published in SciELO: Bibliometric Analysis of Gender Differences.Elizabeth Duran, Katherine Astroza, Jaime Ocaranza-Ozimica, Damary Peñailillo, Iskra Pavez-Soto & Rodrigo Ramirez-Tagle - 2019 - NanoEthics 13 (2):113-118.
Managing financial conflicts of interest in clinical research.Jordan J. Cohen - 2002 - Science and Engineering Ethics 8 (3):401-406.
Financial conflicts and clinical research.Karin Meyers - 2009 - IRB: Ethics & Human Research 31 (4):17.
Kevin Elliott. A Tapestry of Values: An Introduction to Values in Science.Sarah Wieten - 2019 - Philosophy of Science 86 (2):378-383.
Kevin Elliott, "Values in Science.". [REVIEW]Adam Tamas Tuboly - 2023 - Philosophy in Review 43 (4):4-6.
Researcher Perspectives on Conflicts of Interest: A Qualitative Analysis of Views from Academia.Jensen T. Mecca, Carter Gibson, Vincent Giorgini, Kelsey E. Medeiros, Michael D. Mumford & Shane Connelly - 2015 - Science and Engineering Ethics 21 (4):843-855.
Commentary: Evaluating Oversight of Human Drugs and Medical Devices.Susan Bartlett Foote - 2009 - Journal of Law, Medicine and Ethics 37 (4):629-632.
Corporate social responsibility for nanotechnology oversight.Jennifer Kuzma & Aliya Kuzhabekova - 2011 - Medicine, Health Care and Philosophy 14 (4):407-419.

Analytics

Added to PP
2015-02-01

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Author's Profile

Citations of this work

Add more citations

References found in this work

No references found.

Add more references